Dassault Systèmes in Discussions to Acquire ArisGlobal for Approximately $2 Billion

Dassault Systèmes is reportedly in talks to acquire drug trial software company ArisGlobal from Nordic Capital for around $2 billion. The potential deal, if finalized, could expand Dassault's capabilities in the life sciences sector.

By Joshua Fineman, SA News Editor · Seeking Alpha · July 16, 2026, 19:14 UTC

Tickers: $DASTY

Topics: acquisition pharmaceutical software

Read the full article at Seeking Alpha

More World news

Metalla Royalty & Streaming Reports Q3 Revenue Growth and Increased Adjusted EBITDA Seeking Alpha · November 12, 2026, 15:26 UTC
Fed Governor Michael Barr Warns AI Market Concentration Could Drive Income Inequality Seeking Alpha · November 12, 2026, 15:27 UTC
Jefferies Upgrades Pattern Group (PTRN) Following Strong Brand Acquisition Performance Seeking Alpha · November 12, 2026, 15:27 UTC
Pomerantz Law Firm Investigates Six Flags Entertainment Corporation Following Fatal Roller Coaster Accident PR Newswire · November 12, 2026, 15:30 UTC
SpaceX Partners with Qualcomm to Launch Starlink Mobile Cellular Service Motley Fool · November 12, 2026, 15:21 UTC
Blast Resources Appoints Andy Yackulic as CEO to Lead Uranium Exploration PR Newswire · November 12, 2026, 15:26 UTC
FMC Corporation Shares Decline 13% in Thursday Trading Seeking Alpha · November 12, 2026, 15:22 UTC
U.S. Stock Indices Decline Following Nvidia CEO Jensen Huang's Resignation Seeking Alpha · November 12, 2026, 15:23 UTC
EY Report Outlines Three Fundamental Shifts Required for Future-Ready Health Systems by 2040 PR Newswire · November 12, 2026, 15:24 UTC
ProLift Garage Doors Expands Franchise Services and Support Initiatives PR Newswire · November 12, 2026, 15:24 UTC